Fundraising Fox
Vail Scientific
Minneapolis, US · 2 known investors
Find your way into Vail Scientific
Sign up to see every warm intro you have to Vail Scientific
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vail Scientific team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vail Scientific develops VSNO, a non-invasive, point-of-care diagnostic tool for rapid screening of patients suspected of having sepsis to aid in triage. The company serves healthcare providers with medical technology aimed at earlier sepsis diagnosis.
Founders & leadership
TW
TB
JW
Josh WaldmanNamed on SEC filing
RL
Russell L MorrisNamed on SEC filing
Board
CA
Carter AndersonBoard director
MN
Michael NathanBoard directorGeneral Partner at Sagatagan
CC
Curtis CarlsonBoard director
JR
Joshua RobinsonBoard directorGeneral Partner at Sagatagan
Investors · 2
Reported raises · per SEC filings
Form D private placements$8.1M disclosed across 3 of 4 rounds · 2021–2025
▶$7MraisedMar 2025 · 13 investors · BiotechnologyRule 506(b)
▶$7MraisedMar 2025 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Carter R AndersonDirector
- Thomas W. BurkeExecutive Officer
- Clayton J AndersonExecutive Officer, Director
- Michael NathanDirector
- Curtis CarlsonDirector
- Joshua RobinsonDirector
- Offering amount
- $7M
- Amount sold
- $7M
- Placement agents
- The Oak Ridge Financial Services Group, Inc.
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$400KraisedDec 2023 · 2 investors · BiotechnologyRule 506(b)
▶$400KraisedDec 2023 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael NathanDirector
- Clayton J AndersonExecutive Officer, Director
- Carter AndersonDirector
- Curtis R CarlsonDirector
- Russell MorrisDirector
- Thomas BurkeExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $400K
- First sale
- Nov 2023
- Incorporated
- Limited Liability Company, Minnesota, 2019
- Federal exemptions
- 06b
▶$680KraisedAug 2021 · 8 investors · BiotechnologyRule 506(b)
▶$680KraisedAug 2021 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Carter R AndersonDirector
- Tom BurkeExecutive Officer, Director
- Michael NathanDirector
- Josh WaldmanDirector
- Russell L MorrisDirector
- Clayton J AndersonExecutive Officer, Director
- Offering amount
- $937.5K
- Amount sold
- $680K
- First sale
- Jul 2021
- Incorporated
- Limited Liability Company, Minnesota
- Federal exemptions
- 06b, 4a5
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Vail Scientific do?
- Vail Scientific develops VSNO, a non-invasive, point-of-care diagnostic tool for rapid screening of patients suspected of having sepsis to aid in triage. The company serves healthcare providers with medical technology aimed at earlier sepsis diagnosis.
- Who are Vail Scientific's investors?
- Vail Scientific's investors include Exit 156 Capital, Sagatagan.
- How much funding has Vail Scientific raised?
- Vail Scientific has disclosed $8.1M raised across 3 of its 4 known rounds.
- Where is Vail Scientific headquartered?
- Vail Scientific is headquartered in Minneapolis, US.